People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Innovate Biopharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $154.0M | $791.8M | 2018 |
| Mateon Therapeutics Inc | — | Biotechnology | Series B | $45.3M | $1.1M | 2023 |
| Vitality Biopharma, Inc. | — | Pharmaceuticals | Series B | $39.5M | $1.2B | 2012 |
| Sirion Holdings, Inc. | — | Pharmaceuticals | Series B | $30.2M | $941.4M | 2009 |
| ONCOSEC MEDICAL Inc | — | Biotechnology | Series A | $13.6M | $205.5M | 2011 |
Anthony Maida at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Anthony Maida on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Avtar Dhillon | 2 | 4 |
| Peter Barrett | 1 | 18 |
| Amit Shah | 1 | 10 |
| Annalisa Jenkins | 1 | 8 |
| Charles Cohen | 1 | 6 |
| BARRY BUTLER | 1 | 6 |
| Sandeep Laumas | 1 | 6 |
| Andrew Schiff | 1 | 5 |
| Bobby W. Sandage, Jr. | 1 | 5 |
| Daniel O'Connor | 1 | 5 |
| Vuong Trieu | 1 | 5 |
| Todd Creech | 1 | 4 |
| Kevin Kinsella | 1 | 4 |
| Saira Ramasastry | 1 | 4 |
| Punit Dhillon | 1 | 4 |
| Michael Cross | 1 | 3 |
| Edward J. Sitar | 1 | 3 |
| Christopher Prior | 1 | 3 |
| Chulho Park | 1 | 3 |
| James DeMesa | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.